期刊文献+
共找到1,649篇文章
< 1 2 83 >
每页显示 20 50 100
Tumor-infiltrating lymphocytes in the immunotherapy era 被引量:55
1
作者 Sterre T.Paijens Annege Vledder +1 位作者 Marco de Bruyn Hans W.Nijman 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2021年第4期842-859,共18页
The clinical success of cancer immune checkpoint blockade(ICB)has refocused attention on tumor-infiltrating lymphocytes(TILs)across cancer types.The outcome of immune checkpoint inhibitor therapy in cancer patients ha... The clinical success of cancer immune checkpoint blockade(ICB)has refocused attention on tumor-infiltrating lymphocytes(TILs)across cancer types.The outcome of immune checkpoint inhibitor therapy in cancer patients has been linked to the quality and magnitude of T cell,NK cell,and more recently,B cell responses within the tumor microenvironment.State-of-the-art single-cell analysis of TIL gene expression profiles and clonality has revealed a remarkable degree of cellular heterogeneity and distinct patterns of immune activation and exhaustion.Many of these states are conserved across tumor types,in line with the broad responses observed clinically.Despite this homology,not all cancer types with similar TIL landscapes respond similarly to immunotherapy,highlighting the complexity of the underlying tumor-immune interactions.This observation is further confounded by the strong prognostic benefit of TILs observed for tumor types that have so far respond poorly to immunotherapy.Thus,while a holistic view of lymphocyte infiltration and dysfunction on a single-cell level is emerging,the search for response and prognostic biomarkers is just beginning.Within this review,we discuss recent advances in the understanding of TIL biology,their prognostic benefit,and their predictive value for therapy. 展开更多
关键词 Tumor infiltrating lymphocytes B cells T cells Tertiary lymphoid structures IMMUNOTHERAPY
原文传递
Immunopathology of inflammatory bowel disease 被引量:48
2
作者 Kori L Wallace Li-Bo Zheng +1 位作者 Yoshitake Kanazawa David Q Shih 《World Journal of Gastroenterology》 SCIE CAS 2014年第1期6-21,共16页
Inflammatory bowel disease (IBD) results from a complex series of interactions between susceptibility genes, the environment, and the immune system. The host microbiome, as well as viruses and fungi, play important ro... Inflammatory bowel disease (IBD) results from a complex series of interactions between susceptibility genes, the environment, and the immune system. The host microbiome, as well as viruses and fungi, play important roles in the development of IBD either by causing inflammation directly or indirectly through an altered immune system. New technologies have allowed researchers to be able to quantify the various components of the microbiome, which will allow for future developments in the etiology of IBD. Various components of the mucosal immune system are implicated in the pathogenesis of IBD and include intestinal epithelial cells, innate lymphoid cells, cells of the innate (macrophages/monocytes, neutrophils, and dendritic cells) and adaptive (T-cells and B-cells) immune system, and their secreted mediators (cytokines and chemokines). Either a mucosal susceptibility or defect in sampling of gut luminal antigen, possibly through the process of autophagy, leads to activation of innate immune response that may be mediated by enhanced toll-like receptor activity. The antigen presenting cells then mediate the differentiation of na&#x000ef;ve T-cells into effector T helper (Th) cells, including Th1, Th2, and Th17, which alter gut homeostasis and lead to IBD. In this review, the effects of these components in the immunopathogenesis of IBD will be discussed. 展开更多
关键词 Inflammatory bowel disease Crohn’ s disease Ulcerative colitis Microbiome Autophagy T helper 17 Innate immune system Adaptive immune system Innate lymphoid cells TL1A
下载PDF
Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pyloriassociated gastric low-grade marginal zone B-cell lymphoma of MALT type 被引量:28
3
作者 Andrea Morgner Stephan Miehlke +8 位作者 Manfred Stolte Andreas Neubauer Birgit Alpen Christian Thiede Hermann Klann Franz-Xaver Hierlmeier Christian Ell Gerhard Ehninger Ekkehard Bayerdorffer 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第2期248-253,共6页
AIM: To report 3 of 120 patients on the German MALT lymphoma trial with H. pylori associated gastric MALT lymphoma who developed early gastric cancer 4 and 5 years, after complete lymphoma remission following cure of ... AIM: To report 3 of 120 patients on the German MALT lymphoma trial with H. pylori associated gastric MALT lymphoma who developed early gastric cancer 4 and 5 years, after complete lymphoma remission following cure of H. pylori infection. PATIENTS AND RESULTS: Three patients (two men, 74 and 70 years; one women, 77 years) with H. pylori-associated low-grade MALT lymphoma achieved complete lymphoma remission after being cured. Surveillance endoscopies were performed twice a year in accordance to the protocol. Four years after complete lymphoma remission in two patients, and after 5 years in the other, early gastric adenocarcinoma of the mucosa-type, type IIa and type IIc, respectively, was detected, which were completely removed by endoscopic mucosa resection. In one patient, the gastric cancer was diagnosed at the same location as the previous MALT lymphoma, in the other patients it was detected at different sites of the stomach distant from location of the previous MALT lymphoma. The patients were H. pylori negative during the whole follow-up time. CONCLUSION: These findings strengthen the importance of regular Long-term follow-up endoscopies in patients with complete remission of gastric MALT lymphoma after cure of H. pylori infection. Furthermore, gastric adenocarcinoma may develop despite eradication of H. pylori. 展开更多
关键词 Helicobacter pylori ADENOCARCINOMA Aged Disease Susceptibility FEMALE Helicobacter Infections Humans Lymphoma Mucosa-Associated lymphoid Tissue Male Remission Induction Stomach Neoplasms
下载PDF
中医药治疗幽门螺杆菌感染研究进展 被引量:28
4
作者 史彬 刘楠洋 +2 位作者 毕红岩 唐旭东 李振华 《中国中西医结合杂志》 CAS CSCD 北大核心 2017年第4期507-511,共5页
自1982年幽门螺杆菌(Helicobacter pylori,Hp)首次从人胃黏膜组织中分离培养出以来,国内外学者对其进行了30多年的研究,现已证实Hp感染是慢性活动性胃炎、消化性溃疡、胃黏膜相关淋巴组织(mucosa-associated lymphoid tissue,MALT)... 自1982年幽门螺杆菌(Helicobacter pylori,Hp)首次从人胃黏膜组织中分离培养出以来,国内外学者对其进行了30多年的研究,现已证实Hp感染是慢性活动性胃炎、消化性溃疡、胃黏膜相关淋巴组织(mucosa-associated lymphoid tissue,MALT)淋巴瘤和胃癌的主要致病因素。全球有超过50%的人感染有Hp,西方国家感染率为25%-50%。 展开更多
关键词 医药治疗 主要致病因素 lymphoid 胃黏膜组织 淋巴瘤 慢性活动性胃炎 MUCOSA 消化性溃疡 中药复方 复方中药
原文传递
Clinical and prognostic characteristice of pulmonary mucosa- associated lymphoid tissue lymphoma: a retrospective analysis of 23 cases in a Chinese population 被引量:24
5
作者 HUANG Hui LU Zhi-wei +3 位作者 JIANG Chun-guo LI Ji XU Kai XU Zuo-jun 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第7期1026-1030,共5页
Background Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is the most frequent type of non-Hodgkin's lymphoma (NHL) that primarily involves the lungs. It represents a rare entity accounting for less ... Background Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is the most frequent type of non-Hodgkin's lymphoma (NHL) that primarily involves the lungs. It represents a rare entity accounting for less than 1% of all NHLs and the clinical features have yet to be clearly elucidated. 展开更多
关键词 mucosa-associated lymphoid tissue lymphoma lung clinical features
原文传递
慢性淋巴细胞系统白血病免疫表型分析 被引量:24
6
作者 刘艳荣 常艳 +4 位作者 王卉 于弘 高晖 陆道培 陈珊珊 《中华检验医学杂志》 CAS CSCD 北大核心 2003年第1期17-21,共5页
目的 研究国内慢性淋巴细胞系统白血病的免疫表型特点。方法 采用单参数和多参数流式细胞术分析了 16 3例慢性淋巴细胞系统白血病的免疫表型。结果  71 8% ( 117/ 16 3)患者共表达CD5和B细胞标志。采用WHO引用的计分系统 ,将病例分... 目的 研究国内慢性淋巴细胞系统白血病的免疫表型特点。方法 采用单参数和多参数流式细胞术分析了 16 3例慢性淋巴细胞系统白血病的免疫表型。结果  71 8% ( 117/ 16 3)患者共表达CD5和B细胞标志。采用WHO引用的计分系统 ,将病例分为B 慢性淋巴细胞白血病 (B CLL) ,毛细胞白血病 (HCL)和其他B淋巴细胞增殖性疾病。典型的B CLL表达CD5、CD2 3、CD2 0、CD19、HLA DR ,但仍有部分患者表达CD2 2、CD11c、CD2 5和FMC7。CD10 3似为HCL最特异的标志。但仅仅依靠免疫表型难以鉴别非典型B CLL、B细胞 幼淋巴细胞白血病 (B PLL)和外套细胞淋巴瘤 (MCL) ,细胞遗传学或分子生物学检查将有助于鉴别诊断。以同一标本中残存的正常淋巴细胞为内参照 ,计算前向角光散射 (FSC)指数和抗原表达指数 ,可定量地表示细胞的大小和抗原表达的强度 ,使不同的标本具有可比性。结论 免疫表型分析是诊断慢性淋巴细胞系统白血病非常有用的依据。 展开更多
关键词 白血病 淋巴细胞 免疫分型 临床诊断
原文传递
Cellular and molecular regulation of innate inflammatory responses 被引量:21
7
作者 Juan Liu Xuetao Cao 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2016年第6期711-721,共11页
Innate sensing of pathogens by pattern-recognition receptors (PRRs) plays essential roles in the innate discrimination between self and non-self components, leading to the generation of innate immune defense and inf... Innate sensing of pathogens by pattern-recognition receptors (PRRs) plays essential roles in the innate discrimination between self and non-self components, leading to the generation of innate immune defense and inflammatory responses. The initiation, activation and resolution of innate inflammatory response are mediated by a complex network of interactions among the numerous cellular and molecular components of immune and non- immune system. While a controlled and beneficial innate inflammatory response is critical for the elimination of pathogens and maintenance of tissue homeostasis, dysregulated or sustained inflammation leads to pathological conditions such as chronic infection, inflammatory autoimmune diseases. In this review, we discuss some of the recent advances in our understanding of the cellular and molecular mechanisms for the establishment and reJzulation of innate immunity and inflammatory responses. 展开更多
关键词 dendritic cells INFLAMMATION innate lymphoid cells innate signaling pattern-recognition receptors (PRRs)
原文传递
Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond 被引量:21
8
作者 Angelo Zullo Cesare Hassan +2 位作者 Francesca Cristofari Francesco Perri Sergio Morini 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2010年第4期181-186,共6页
The stomach is the most frequently involved site for extranodal lymphomas,accounting for nearly two-thirds of all gastrointestinal cases.It is widely accepted that gastric B-cell,low-grade mucosal-associated lymphoid ... The stomach is the most frequently involved site for extranodal lymphomas,accounting for nearly two-thirds of all gastrointestinal cases.It is widely accepted that gastric B-cell,low-grade mucosal-associated lymphoid tissue(MALT)-lymphoma is caused by Helicobacter pylori(H.pylori)infection.MALT-lymphomas may engender different clinical and endoscopic patterns.Often,diagnosis is confirmed in patients with only vague dyspeptic symptoms and without macroscopic lesions on gastric mucosa.H.pylori eradication leads to lymphoma remission in a large number of patients when treatment occurs at an early stage(Ⅰ-Ⅱ1).Neoplasia confined to the submucosa,localized in the antral region of the stomach,and without API2-MALT1 translocation,shows a high probability of remission following H.pylori eradication.When both bacterial infection and lymphoma recur,further eradication therapy is generally effective.Radiotherapy,chemotherapy and,in selected cases,surgery are the available therapeutic options with a high success rate for those patients who fail to achieve remission,while data on immunotherapy with monoclonal antibodies (rituximab)are still scarce.The 5-year survival rate is higher than 90%,but careful,long-term follow-up is required in these patients since lymphoma recurrence has been reported in some cases. 展开更多
关键词 Mucosal-associated lymphoid tissue Therapy Helicobacter pylori GASTRIC LYMPHOMA Predictive factors Endoscopy Clinical presentation
下载PDF
Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses 被引量:22
9
作者 Rama Krishna Gurram Jinfang Zhu 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2019年第3期225-235,共11页
The type 2 immune response is critical for host defense against large parasites such as helminths.On the other hand,dysregulation of the type 2 immune response may cause immunopathological conditions,including asthma,... The type 2 immune response is critical for host defense against large parasites such as helminths.On the other hand,dysregulation of the type 2 immune response may cause immunopathological conditions,including asthma,atopic dermatitis,rhinitis,and anaphylaxis.Thus,a balanced type 2 immune response must be achieved to mount effective protection against invading pathogens while avoiding immunopathology.The classical model of type 2 immunity mainly involves the differentiation of type 2 T helper(Th2)cells and the production of distinct type 2 cytokines,including interleukin-4(IL-4),IL-5,and IL-13.Group 2 innate lymphoid cells(ILC2s)were recently recognized as another important source of type 2 cytokines.Although eosinophils,mast cells,and basophils can also express type 2 cytokines and participate in type 2 immune responses to various degrees,the production of type 2 cytokines by the lymphoid lineages,Th2 cells,and ILC2s in particular is the central event during the type 2 immune response.In this review,we discuss recent advances in our understanding of how ILC2s and Th2 cells orchestrate type 2 immune responses through direct and indirect interactions. 展开更多
关键词 Type 2 immune response type 2 T helper cell(Th2) Group 2 innate lymphoid cell(ILC2) Allergy and asthma
原文传递
CCLG-2008方案治疗标危中危儿童急性淋巴细胞白血病中期随访结果 被引量:20
10
作者 刘晓明 邹尧 +14 位作者 王慧君 陈晓娟 阮敏 陈玉梅 杨文钰 郭晔 刘天峰 张丽 王书春 张家源 刘芳 蔡小矜 戚本泉 常丽贤 竺晓凡 《中华儿科杂志》 CAS CSCD 北大核心 2014年第6期449-454,共6页
目的 评价根据骨髓微小残留病(MRD)检测调整儿童急性淋巴细胞白血病(ALL)危险度分组的意义.方法 前瞻性选取2008年4月至2011年8月于中国医学科学院血液病医院就诊并采用CCLG-2008方案系统治疗的初诊标危、中危ALL患儿共285例,其中男... 目的 评价根据骨髓微小残留病(MRD)检测调整儿童急性淋巴细胞白血病(ALL)危险度分组的意义.方法 前瞻性选取2008年4月至2011年8月于中国医学科学院血液病医院就诊并采用CCLG-2008方案系统治疗的初诊标危、中危ALL患儿共285例,其中男179例(62.8%)、女106例(37.2%),年龄5.3(0.5 ~14.0)岁.无需涉及MRD调整危险度分组已定义为高危组的初诊ALL患儿不在本研究范围.根据初次于本院确诊并入组的时间分组:Ⅰ组:2008年4月至2009年12月的初诊,共126例,均按CCLG-2008方案设定的危险度分组进行划分及治疗,且未根据骨髓MRD水平调整危险度分组及治疗方案;Ⅱ组:2010年1月至2011年8月初诊患儿,共159例,除按CCLG-2008方案设定的危险度分组进行划分及治疗外,在治疗过程中将根据不同时期(诱导治疗的第33天以及整体治疗的第12周)MRD的水平调整其危险度分组及治疗方案.两组患儿均采用四色荧光抗体标记的流式细胞仪进行MRD检测.组间比较采用t或x2检验,生存曲线采用Kaplan-Meier分析,多因素分析采用Cox回归分析.结果 本组285例患儿中B细胞型268例(94.0%),T细胞型17例(6.0%);中枢神经系统(CNS)1状态232例(81.4%),CNS 2状态48例(16.8%),CNS 3状态5例(1.8%).Ⅰ组标危78例(61.9%),中危48例(38.1%);Ⅱ组调整前标危109例(68.6%),中危50例(31.4%),调整后标、中、高危比例分别为:53.5%(85例)、39.6%(63例)和6.9%(11例).285例患儿均随访2.5年,总复发率为7.4%(21例),Ⅰ组和Ⅱ组分别为12.7%(16例)和3.1%(5例)(P=0.009);败血症、侵袭性真菌感染、坏死性小肠炎等较为严重感染的发生率为32.3%(92/285),Ⅰ组和Ⅱ组分别为28.6%(36/126)和35.2% (56/159) (P =0.392);总病死率为6.7%(19/285),Ⅰ组和Ⅱ组分别为10.3%(13/126)和3.8% (6/159) (P =0.044).� 展开更多
关键词 儿童 白血病 淋巴样 预后 微小残留病
原文传递
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids 被引量:19
11
作者 Chang H.Kim 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2021年第5期1161-1171,共11页
A mounting body of evidence indicates that dietary fiber(DF)metabolites produced by commensal bacteria play essential roles in balancing the immune system.DF,considered nonessential nutrients in the past,is now consid... A mounting body of evidence indicates that dietary fiber(DF)metabolites produced by commensal bacteria play essential roles in balancing the immune system.DF,considered nonessential nutrients in the past,is now considered to be necessary to maintain adequate levels of immunity and suppress inflammatory and allergic responses.Short-chain fatty acids(SCFAs),such as acetate,propionate,and butyrate,are the major DF metabolites and mostly produced by specialized commensal bacteria that are capable of breaking down DF into simpler saccharides and further metabolizing the saccharides into SCFAs.SCFAs act on many cell types to regulate a number of important biological processes,including host metabolism,intestinal functions,and immunity system.This review specifically highlights the regulatory functions of DF and SCFAs in the immune system with a focus on major innate and adaptive lymphocytes.Current information regarding how SCFAs regulate innate lymphoid cells,T helper cells,cytotoxic T cells,and B cells and how these functions impact immunity,inflammation,and allergic responses are discussed. 展开更多
关键词 MICROBIOTA Dietary fiber Short-chain fatty acids Innate lymphoid cells B cells TH1 TH17 TREGS CD8 Microbial metabolites
原文传递
伊马替尼联合化疗或异基因造血干细胞移植治疗成人Ph染色体阳性急性淋巴细胞白血病的临床研究 被引量:18
12
作者 程珍 赵澜 +8 位作者 陈广华 吴德沛 仇惠英 唐晓文 傅琤琤 金正明 陈峰 薛胜利 孙爱宁 《中华血液学杂志》 CAS CSCD 北大核心 2014年第2期114-119,共6页
目的探讨伊马替尼在初治成人Ph染色体阳性急性淋巴细胞白血病(Ph+ALL)诱导治疗中的作用,以及在伊马替尼时代异基因造血干细胞移植(allo.HSCT)在治疗成人Ph+ALL中的地位。方法回顾性分析2005-2013年就诊的97例初治成人Ph+ALL患... 目的探讨伊马替尼在初治成人Ph染色体阳性急性淋巴细胞白血病(Ph+ALL)诱导治疗中的作用,以及在伊马替尼时代异基因造血干细胞移植(allo.HSCT)在治疗成人Ph+ALL中的地位。方法回顾性分析2005-2013年就诊的97例初治成人Ph+ALL患者,根据首次诱导治疗过程中伊马替尼使用情况,分为使用组(37例,用伊马替尼≥3d)与未使用组(60例,未用或用伊马替尼〈3d),并将使用组分为前期使用组(26例)与后期使用组(11例)(以化疗第14天为界),比较各组的总反应率(ORR)以及获得完全缓解(CR)或CR伴血细胞不完全恢复(CRi)患者的BCR.ABL融合基因转阴率。之后有77例患者使用伊马替尼作为维持治疗,其中接受allo-HSCT患者44例(移植组),未进行移植者33例(非移植组)。比较两组的总生存(OS)率、无病生存(DFS)率、复发率及非复发死亡(NRM)率;并监测34例移植前处于首次完全缓解(CR。)状态的患者分别在取得CR或CRi时、首次巩固治疗时、移植预处理前、移植造血重建时的融合基因转阴率。结果首次诱导治疗结束时,伊马替尼使用组ORR高于未使用组(分别为97.3%和72.9%,P=0.002),而前期使用组与后期使用组的ORR差异无统计学意义(分别为100%和90.9%,P=0.297);使用组与未使用组中获得CR或CRi患者的融合基因转阴率分别为20.0%和o(P=O.041)。移植前处于CR、状态的患者于上述4个时间点的融合基因转阴率分别为20.8%、42.3%、51.8%、76.8%,移植造血重建时与移植预处理前、移植预处理前与获得CR或CRi时相比较,差异有统计学意义(P值分别为0.044和0.022)。移植组5年OS率高于非移植组(分别为47.0%和28.0%,P=0.016),5年DFS率及累积复发率均优于非移植组(P值分别为0.003和0.000),而两组的NRM累积发生 展开更多
关键词 白血病 淋巴样 费城染色体 伊马替尼 造血干细胞移植
原文传递
Anti-cd TCR antibody-expanded cd T cells:a better choice for the adoptive immunotherapy of lymphoid malignancies 被引量:18
13
作者 Jianhua Zhou Ning Kang +2 位作者 Lianxian Cui Denian Ba Wei He 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2012年第1期34-44,共11页
Cell-based immunotherapy for lymphoid malignancies has gained increasing attention as patients develop resistance to conventional treatments.cd T cells,which have major histocompatibility complex(MHC)-unrestricted lyt... Cell-based immunotherapy for lymphoid malignancies has gained increasing attention as patients develop resistance to conventional treatments.cd T cells,which have major histocompatibility complex(MHC)-unrestricted lytic activity,have become a promising candidate population for adoptive cell transfer therapy.We previously established a stable condition for expanding cd T cells by using anti-cd T-cell receptor(TCR)antibody.In this study,we found that adoptive transfer of the expanded cd T cells to Daudi lymphoma-bearing nude mice significantly prolonged the survival time of the mice and improved their living status.We further investigated the characteristics of these antibody-expanded cd T cells compared to the more commonly used phosphoantigen-expanded cd T cells and evaluated the feasibility of employing them in the treatment of lymphoid malignancies.Slow but sustained proliferation of human peripheral blood cd T cells was observed upon stimulation with anti-cd TCR antibody.Compared to phosphoantigen-stimulated cd T cells,the antibody-expanded cells manifested similar functional phenotypes and cytotoxic activity towards lymphoma cell lines.It is noteworthy that the anti-cd TCR antibody could expand both the Vd1 and Vd2 subsets of cd T cells.The in vitro-expanded Vd1 T cells displayed comparable tumour cell-killing activity to Vd2 T cells.Importantly,owing to higher C–C chemokine receptor 4(CCR4)and CCR8 expression,the Vd1 T cells were more prone to infiltrate CCL17-or CCL22-expressing lymphomas than the Vd2 T cells.Characterizing the peripheral blood cd T cells from lymphoma patients further confirmed that the anti-cd TCR antibody-expanded cd T cells could be a more efficacious choice for the treatment of lymphoid malignancies than phosphoantigen-expanded cd T cells. 展开更多
关键词 adoptive cell therapy anti-cd TCR antibody cd T cells lymphoid malignancies Vd1 subset
原文传递
Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome 被引量:17
14
作者 Cheng Kong Xuebing Yan +8 位作者 Yongqiang Liu Linsheng Huang Yefei Zhu Jide He Renyuan Gao Matthew F.Kalady Ajay Goel Huanlong Qin Yanlei Ma 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第5期1573-1584,共12页
Accumulating evidence suggests that ketogenic diets(KDs)mediate the rise of circulating ketone bodies and exert a potential antiinflammatory effect;however,the consequences of this unique diet on colitis remain unknow... Accumulating evidence suggests that ketogenic diets(KDs)mediate the rise of circulating ketone bodies and exert a potential antiinflammatory effect;however,the consequences of this unique diet on colitis remain unknown.We performed a series of systematic studies using a dextran sulfate sodium(DSS)animal model of inflammatory colitis.Animals were fed with a KD,low-carbohydrate diet(LCD),or normal diet(ND).Germ-free mice were utilized in validation experiments.Colon tissues were analyzed by transcriptome sequencing,RT2 profiler PCR array,histopathology,and immunofluorescence.Serum samples were analyzed by metabolic assay kit.Fecal samples were analyzed by 16S rRNA gene sequencing,liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry.We observed that KD alleviated colitis by altering the gut microbiota and metabolites in a manner distinct from LCD.Quantitative diet experiments confirmed the unique impact of KD relative to LCD with a reproducible increase in Akkermansia,whereas the opposite was observed for Escherichia/Shigella.After colitis induction,the KD protected intestinal barrier function,and reduced the production of R0Ryt+CD3_group 3 innate lymphoid cells(ILC3s)and related inflammatory cytokines(IL-17a,IL-18,IL-22,Ccl4).Finally,fecal microbiota transplantation into germ-free mice revealed that the KD-mediated colitis inhibition and ILC3 regulation were dependent on the modification of gut microbiota.Taken together,our study presents a global view of microbiome-metabolomics changes that occur during KD colitis treatment,and identifies the regulation of gut microbiome and ILC3s as novel targets involving in IBD dietary therapy. 展开更多
关键词 COLITIS lymphoid consequences
原文传递
Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma 被引量:14
15
作者 Hyung Soon Park Yu Jin Kim +2 位作者 Woo Ick Yang Chang Ok Suh Yong Chan Lee 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第17期2158-2162,共5页
AIM: To investigate treatment outcome of Helicobacter pylori (H.pylori )-negative low-grade gastric mucosaassociated lymphoid tissue (MALT) lymphoma.METHODS: In this study,we retrospectively reviewed the clinical outc... AIM: To investigate treatment outcome of Helicobacter pylori (H.pylori )-negative low-grade gastric mucosaassociated lymphoid tissue (MALT) lymphoma.METHODS: In this study,we retrospectively reviewed the clinical outcome and clinicopathologic factors of stage Ⅰ E H.pylori -negative low-grade gastric MALT lymphoma cases from August 1998 to June 2009.RESULTS: A total of eleven patients with H.pylori -negative low-grade gastric MALT lymphoma were enrolled in the study and received anti-H.pylori eradication treatment and/or radiotherapy or excisional therapy.Complete remission (CR) of gastric MALT lymphoma was achieved in all patients.The time to CR was 1-66 mo (median,1 mo).CONCLUSION: Eradication therapy may be offered as an initial treatment option even in cases of localized H.pylori -negative gastric MALT lymphoma. 展开更多
关键词 Anti-bacterial agents Helicobacter pylori Mucosa-associated lymphoid tissue lymphoma RADIOTHERAPY STOMACH
下载PDF
Targeting natural killer cells in solid tumors 被引量:16
16
作者 Guillaume Habif Adeline Crinier +2 位作者 Pascale Andre Eric Vivier Emilie Narni-Mancinelli 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2019年第5期415-422,共8页
Natural killer(NK)cells are innate lymphoid cells endowed with cytolytic activity and a capacity to secrete cytokines and chemokines.Several lines of evidence suggest that NK cells play an important role in anti-tumor... Natural killer(NK)cells are innate lymphoid cells endowed with cytolytic activity and a capacity to secrete cytokines and chemokines.Several lines of evidence suggest that NK cells play an important role in anti-tumor immunity.Some therapies against hematological malignacies make use of the immune properties of NK cells,such as their ability to kill residual leukemic blasts efficiently after conditioning during haploidentical hematopoietic stem cell transplantation.However,knowledge on NK cell infiltration and the status of NK cell responsiveness in solid tumors is limited so far.The pro-angiogenic role of the recently described NK cell-like type 1 innate lymphoid cells(ILC1s)and their phenotypic resemblance to NK cells are confounding factors that add a level of complexity,at least in mice.Here,we review the current knowledge on the presence and function of NK cells in solid tumors as well as the immunotherapeutic approaches designed to harness NK cell functions in these conditions,including those that aim to reinforce conventional anti-tumor therapies to increase the chances of successful treatment. 展开更多
关键词 KILLER TUMORS lymphoid
原文传递
The immune modifying effects of amino acids on gut-associated lymphoid tissue 被引量:13
17
作者 Megan R Ruth Catherine J Field 《Journal of Animal Science and Biotechnology》 SCIE CAS 2013年第3期195-204,共10页
The intestine and the gut-associated lymphoid tissue(GALT) are essential components of whole body immune defense,protecting the body from foreign antigens and pathogens,while allowing tolerance to commensal bacteria... The intestine and the gut-associated lymphoid tissue(GALT) are essential components of whole body immune defense,protecting the body from foreign antigens and pathogens,while allowing tolerance to commensal bacteria and dietary antigens.The requirement for protein to support the immune system is well established.Less is known regarding the immune modifying properties of individual amino acids,particularly on the GALT.Both oral and parenteral feeding studies have established convincing evidence that not only the total protein intake,but the availability of specific dietary amino acids(in particular glutamine,glutamate,and arginine,and perhaps methionine,cysteine and threonine) are essential to optimizing the immune functions of the intestine and the proximal resident immune cells.These amino acids each have unique properties that include,maintaining the integrity,growth and function of the intestine,as well as normalizing inflammatory cytokine secretion and improving T-lymphocyte numbers,specific T cell functions,and the secretion of IgA by lamina propria cells.Our understanding of this area has come from studies that have supplemented single amino acids to a mixed protein diet and measuring the effect on specific immune parameters.Future studies should be designed using amino acid mixtures that target a number of specific functions of GALT in order to optimize immune function in domestic animals and humans during critical periods of development and various disease states. 展开更多
关键词 Amino acids ARGININE EPITHELIUM Glutamate GLUTAMINE Gut-associated lymphoid tissue INTESTINE MUCOSA
下载PDF
嵌合抗原受体T细胞治疗儿童复发、难治急性B淋巴细胞白血病48例的长期疗效分析 被引量:15
18
作者 左英熹 贾月萍 +5 位作者 吴珺 王静波 陆爱东 董陆佳 张隆基 张乐萍 《中华血液学杂志》 CAS CSCD 北大核心 2019年第4期270-275,共6页
目的评价嵌合抗原受体(CAR)T细胞技术治疗复发、难治儿童急性B淋巴细胞白血病(B-ALL)的疗效,探讨影响预后的因素。方法2014年9月至2017年8月应用第四代CD19特异性CAR-T细胞治疗复发、难治CD19阳性B-ALL/B淋巴母细胞性淋巴瘤患儿48例,其... 目的评价嵌合抗原受体(CAR)T细胞技术治疗复发、难治儿童急性B淋巴细胞白血病(B-ALL)的疗效,探讨影响预后的因素。方法2014年9月至2017年8月应用第四代CD19特异性CAR-T细胞治疗复发、难治CD19阳性B-ALL/B淋巴母细胞性淋巴瘤患儿48例,其中男29例,女19例,中位年龄8(3~17)岁。48例患儿共接受61次CAR-T细胞输注,观察输注后的不良反应,治疗前后应用流式细胞术或实时定量聚合酶链反应方法监测白血病微小残留病(MRD)水平。中位随访时间406(16~1 259)d。结果61例次CAR-T细胞输注过程中均无不良反应。CAR-T细胞输注后最常见的不良反应为细胞因子释放综合征(CRS)。仅2例患儿出现3级CRS表现,包括持续高热、惊厥、谵妄、浆膜腔积液、血压下降等,1例经对症治疗后好转,另1例应用妥珠单抗治疗后缓解。无一例患者发生CAR-T细胞治疗相关死亡。CAR-T细胞治疗反应率为77.1%,反应出现的时间为输注后第7~28天,CAR-T细胞输注前肿瘤负荷<5%组与≥5%组的反应率分别为87.1%和58.8%(χ^2=4.968,P=0.036)。对于有治疗反应的37例患儿,2年总生存率和年龄、疾病状态及CAR-T细胞输注前的肿瘤负荷相关(P<0.05);而CAR-T细胞输注前的肿瘤负荷≥5%[RR=3.433(95%CI 1.333~8.844),P=0.011]及未桥接造血干细胞移植(HSCT)[RR=4.996(95%CI 1.852~13.474),P=0.001]是影响患儿无事件生存的独立危险因素。结论抗CD19的CAR-T细胞技术治疗儿童复发、难治B-ALL安全有效。通过有效的预处理手段,尽可能降低CAR-T细胞输注前的肿瘤负荷有利于提高CAR-T细胞治疗的反应率。对于难治性白血病或仅分子水平复发的患儿进行CAR-T细胞治疗后桥接HSCT可能是更优的治疗策略。 展开更多
关键词 嵌合抗原受体 白血病 淋巴样 复发 难治 儿童
原文传递
Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma 被引量:12
19
作者 Jeong Bae Park Ja Seol KooJeong 《World Journal of Gastroenterology》 SCIE CAS 2014年第11期2751-2759,共9页
Gastrointestinal lymphoma is the most common type of extranodal lymphoma,and most commonly affects the stomach.Marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue(MALT)and diffuse large B-cell lymph... Gastrointestinal lymphoma is the most common type of extranodal lymphoma,and most commonly affects the stomach.Marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue(MALT)and diffuse large B-cell lymphoma are the most common histologic types of gastric lymphoma.Despite its increasing incidence,diagnosis of gastric lymphoma is difficult at an earlier stage due to its nonspecific symptoms and endoscopic findings,and,thus,a high index of suspicion,and multiple,deep,repeated biopsies at abnormally and normally appearing sites in the stomach are needed.In addition,testing for Helicobacter pylori(H.pylori)infection and endoscopic ultrasonography to determine the depth of tumor invasion and involvement of regional lymph nodes is essential for predicting response to H.pylori eradication and for assessment of disease progression.In addition,H.pylori infection and MALT lymphoma development are associated,and complete regression of low-grade MALT lymphomas after H.pylori eradication has been demonstrated.Radiotherapy and/or chemotherapy can be used in cases that show poor response to H.pylori eradication,negativity for H.pylori infection,or high-grade lymphoma. 展开更多
关键词 Mucosa-associated lymphoid tissue LYMPHOMA Helicobacter pylori ERADICATION REMISSION
下载PDF
Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma 被引量:14
20
作者 Qunxing Li Xiangqi Liu +6 位作者 Dikan Wang Yanqiong Wang Huanzi Lu Shuqiong Wen Juan Fang Bin Cheng Zhi Wang 《International Journal of Oral Science》 SCIE CAS CSCD 2020年第3期227-234,共8页
Tertiary lymphoid structures(TLS)are ectopic lymphoid structures in cancers that are largely associated with favourable prognosis.However,the prognostic value of TLSs in oral squamous cell carcinoma(OSCC)is largely un... Tertiary lymphoid structures(TLS)are ectopic lymphoid structures in cancers that are largely associated with favourable prognosis.However,the prognostic value of TLSs in oral squamous cell carcinoma(OSCC)is largely unknown,and the association between tumour infiltrating lymphocytes(TILs)and TLSs has been rarely explored in OSCC.In this study,associated markers of TLS,including peripheral node address(PNAd)in high endothelial venules,CD20 in B cells and CD3 in T cells,were examined in 168 OSCC patients,and survival analysis was performed between TLS-positive and TLS-negative cohorts.We detected the presence of TILs by staining CD8+cytotoxic T cells and CD57+NK cells as well.TLSs appeared as highly organized structures in 45(26.8%)cases.TLSpositive patients had a better 5-year overall survival(OS)rate(88.9%vs.56.1%,P<0.001)and relapse-free survival(RFS)rate(88.9%vs.63.4%,P=0.002).Moreover,the presence of TLS was an independent prognostic factor for both the 5-year OS rate(hazard ratio[HR]=3.784;95%confidence interval[CI],1.498–9.562)and RFS rate(HR=3.296;95%CI,1.279–8.490)in multivariate analysis.Furthermore,a higher density of CD8+T cells and CD57+NK cells was found in TLS-positive sections than in TLS-negative counterparts(P<0.001),and their combination provided a higher predictive accuracy(AUC=0.730;95%CI,0.654–0.805).In conclusion,our results suggest that TLS is an independent positive prognostic factor for OSCC patients.These findings provide a theoretical basis for the future diagnostic and therapeutic value of TLSs in OSCC treatment. 展开更多
关键词 LYMPHOCYTES lymphoid infiltrating
下载PDF
上一页 1 2 83 下一页 到第
使用帮助 返回顶部